2024/05/03 17:33:01 | |
---|---|
Price | |
0.0012 CHF | |
Difference | -76.92% (-0.00) |
ISIN | CH1260041939 |
Symbol | OBSN |
Exchange | SIX Swiss Exchange |
Currency | CHF |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 0 EUR |
Benchmark | SWISS MARKET INDEX |
Bid (Bid size) | 0.0012 CHF (39,800) |
Ask (Ask size) | 0.0012 CHF (11,245) |
Open | 0.005 CHF |
High | 0.0058 CHF |
Low | 0.0012 CHF |
Close (prev. day) | 0.0052 CHF |
VWAP | 0.00435 CHF |
Volume (pcs) | 2,351,202 |
Trading volume | 10,228.74 |
Number of trades | 51 |
Last size | 3,755 |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/07/12 | Global Equity Ratings | ||
2024/06/21 | Global Equity Ratings | ||
2024/06/14 | Global Equity Ratings | ||
2024/05/29 | Global Equity Ratings | ||
2024/04/26 | Global Equity Ratings |
2024/05/03 17:33:01 | |
---|---|
Price | |
0.0012 CHF | |
Difference | -76.92% (-0.00) |
ISIN | CH1260041939 |
Symbol | OBSN |
Exchange | SIX Swiss Exchange |
Currency | CHF |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 0 EUR |
Benchmark | SWISS MARKET INDEX |
Bid (Bid size) | 0.0012 CHF (39,800) |
Ask (Ask size) | 0.0012 CHF (11,245) |
Open | 0.005 CHF |
High | 0.0058 CHF |
Low | 0.0012 CHF |
Close (prev. day) | 0.0052 CHF |
VWAP | 0.00435 CHF |
Volume (pcs) | 2,351,202 |
Trading volume | 10,228.74 |
Number of trades | 51 |
Last size | 3,755 |
6m | 1Y | 3Y | |
Perf (%) | -97.39% | -98.66% | -99.96% |
Perf (abs.) | -0.04 | -0.09 | -2.76 |
Beta | -164.32 | -77.01 | -11.11 |
Volatility | 385.99 | 277.68 | 195.40 |
Ø price 5 days | Ø volume 5 days (pcs.) | 0.0058 CHF (910,404) |
Ø price 30 days | Ø volume 30 days (pcs.) | 0.0079 CHF (610,179) |
Ø price 100 days | Ø volume 100 days (pcs.) | 0.0305 CHF (439,836) |
Ø price 250 days | Ø volume 250 days (pcs.) | 0.0484 CHF (238,373) |
YTD High | date | 0.0800 CHF (2024/01/23) |
YTD Low | date | 0.0012 CHF (2024/05/03) |
52 Weeks High | date | 0.0890 CHF (2023/05/04) |
52 Weeks Low | date | 0.0012 CHF (2024/05/03) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
SIX Swiss Exchange | 2024/05/03 | 17:33 | 0.0012 CHF | 0.01 | 51 |
Frankfurt | 2019/06/28 | 15:43 | 9.22 EUR | 0.00 | 2 |
FINRA other OTC Issues | 2024/07/16 | 21:52 | 0.0000 USD | 0.00 | 3 |
Berlin | 2019/06/28 | 08:02 | 9.12 EUR | 0.00 | 1 |
OBSEVA SA |
- - |
Chemin des Aulx, 12, Plan-les-Ouates - 1228 Genf |
Telefon: +41-22-552-38-40 |
Fax: + |
E-mail: contact@obseva.ch |
ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women's reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland. |
Fabien de Ladonchamps | Chairman of Managing Board |
Luigi Marro | Member of the administrative board |
Ernest Loumaye | Chairman of the administrative boar |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer